EU agencies to advise on risks from phenylbutazone in horsemeat

Author (Corporate)
Series Title
Series Details 07.03.2013
Publication Date 07/03/2013
Content Type

The European Commission, in March 2013, asked the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) to carry out a joint assessment of the risks to human health from the presence in horsemeat of residues of the anti-inflammatory drug phenylbutazone. The request followed the identification of beef products contaminated with horsemeat and the discovery of phenylbutazone – also known as 'bute' – in a small number of horse carcasses intended for the food chain.
Source Link Link to Main Source http://www.efsa.europa.eu/en/press/news/130307.htm
Related Links
EMA: News, 07.03.13: EU agencies to advise on risks from phenylbutazone in horsemeat http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/03/news_detail_001731.jsp
EFSA: FAQ on Phenylbutazone in horsemeat http://www.efsa.europa.eu/en/faqs/phenylbutazone.htm?wtrl=01
EFSA: Topics: Meat inspection http://www.efsa.europa.eu/en/topics/topic/meatinspection.htm
EFSA: News, 15.04.13: EU agencies consider phenylbutazone detected in horsemeat of low concern for consumers; recommend improved horse traceability and monitoring of veterinary medicinal residues http://www.efsa.europa.eu/en/press/news/130415.htm
Subject Categories
Countries / Regions